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This study was undertaken to compare amino acid concentrations in maternal and newborn infants’ serum in normal pregnancy and two groups of
obese women who were born themselves with normal and small for gestational age (SGA) birth weight. Maternal cholesterol, lipoproteins
concentrations and maternal and infants amino acid concentrations were evaluated at the time of delivery in 28 normal pregnancies, 46 obese
pregnant women with normal birth weight (Ob-AGA group) and 44 obese pregnant women born themselves SGA (Ob-SGA group). Mean birth
weight of newborn infants in Ob-SGA group was significantly less than in normal and Ob-AGA groups. Cholesterol and lipoproteins were
significantly elevated in obese women (more prominent in Ob-SGA group). Most amino acid concentrations and fetal–maternal amino acid
gradients were significantly lower in Ob-SGA group. These data suggest significant changes in placental amino acid transport/synthetic function in
obese women who were born themselves SGA.
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Introduction
The prevalence of obesity among pregnant women in the world
is increasing. In addition to the short-term complications of
obesity during pregnancy in both mother and child, it has now
been demonstrated that maternal obesity has long-term adverse
effects, including childhood obesity and health risks for these
children in later life.1,2
The main concern is that the rising rates of childhood obe-
sity will promote an epidemic of chronic diseases such as heart
disease, arterial hypertension and ‘type 2’ diabetes. One view is
that childhood obesity and adult diseases are being initiated by
excess nutrition in utero or during infancy. People who become
obese tend to have had a high birth weight and above average
weight through infancy.3,4 Although fetuses of women with
obesity appear to be exposed to an excess of circulating nutri-
ents, they may not benefit as a result.
In many cases, however, early life development that leads to
obesity-related disease begins with low birth weight and small
body size during infancy.5–7
Amino acids used both for protein synthesis and energy
production represent together with glucose, fatty acids and
lactate, the main nutrients during intrauterine growth.8
Fetal protein synthesis is dependent on both amino acid and
energy supply. During positive energy balance, glucose and
fatty acids utilization as fuel substitute for amino acids. In this
reciprocal manner energy supply and amino acid metabolism
are closely balanced.
A relationship has been demonstrated between metabolism of
amino acids and apolipoproteins.9 Because of the incorporation
into apolipoproteins synthesis, various amino acids such as leu-
cine, glycine, valine, lysine, arginine and phenylalanine labeled
with different stable isotopes have been used as tracers to study
the metabolism of apolipoproteins A, B, C and E.10
Active amino acid transport via micro-villous and basal
membranes of the trophoblast together with placental synthesis
of some non-essential amino acids result in higher amino acid
concentrations in fetal than in maternal serum.11,12
Studies in preeclampsia and type 1 diabetic mothers have
reported a significant increase in most amino acids concentra-
tions in both mother and fetus.13,14 In women with pre-
eclampsia several amino acids demonstrated significant inverse
correlations with fetal head circumference.14 In diabetic
women a significant changes in fetal/maternal amino acid
concentration differences were also shown, suggesting altera-
tion in placental amino acids exchange and/or fetal/placental
amino acids metabolism.13
However, no data are available on the relationship between
amino acid concentrations in both newborn infant and maternal
serum in pregnancies associated with maternal obesity.
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The objective of this investigation was to study maternal
cholesterol and lipoprotein metabolism and maternal and fetal
amino acid concentrations from pregnancies associated with
maternal obesity in two groups of obese women who were born
with normal and low birth weight themselves. We hypothesize
to find differences in pregnancy outcome and serum amino
acids concentrations in both mother and fetus when maternal
intrauterine development was normal or complicated by
growth restriction. We also hypothesize there exists a relation-
ship between apolipoprotein and maternal serum amino acid
concentrations.
Materials and methods
Subjects
A total of 118 nulliparous subjects were recruited (2007–2012)
and gave their informed consent at admission to labor and
delivery at Mother and Child Research Institute (Yekaterin-
burg, Russia) as a part of ongoing investigation of maternal
obesity approved by the institutional ethics committee.
Twenty-eight healthy, normal weight (BMI< 25 kg/m2)
with no significant past medical history women were included
in the control group. Forty-six women with obesity
(BMI> 30 kg/m2) and normal birth weight were included in
Ob-AGA group. Forty-four pregnant women with obesity
(BMI> 30 kg/m2) who themselves were small for gestational
age (SGA) at birth were included in Ob-SGA group (Table 1).
All women were non-smokers. The information on maternal
birth weight was obtained from medical documentation related
to birth certificate kept by the parents of pregnant women.
Small for gestational age women were defined as those who
were less than the 10th percentile for birth weight corrected for
gestational age and sex.15 The criteria for exclusion in the
control, Ob-AGA and Ob-SGA groups were hypertension,
proteinuria and hyperuricemia. Hypertension was defined as a
blood pressure more than 140/90 mmHg. Proteinuria was
defined as >300 mg per 24 h urine collection. Hyperuricemia
was defined as >5.5 mg/dl at term.
Fetal gestational age was calculated from the last menstrual
period and confirmed by ultrasound before 20 weeks of gesta-
tion. For the neonates, gestational age at delivery, birth weight
and length, sex and placenta weight were recorded.
Blood samples
Blood samples were collected at the time of delivery from
maternal brachial vein after a 12-h overnight fasting as well as
from umbilical vein in tubes containing 1.0 mg/ml Na2EDTA.
Maternal and cord-blood serum samples were allowed to
stand at room temperature for 1 h, centrifuged at 2000 g for
20 min, aliquoted under sterile conditions and then stored at
−80°C until they were assayed. For analysis plasma was quickly
thawed and deproteinized with a solution of 10% sulfosalicylic
acid with norleucine added as an internal standard and buffered
with lithium hydroxide to pH 2.2. Samples were centrifuged at
14,000 rpm for 10 min and the supernatant fraction was
filtered throughout a Millipore (Millipore Corp, Bedford, MA,
USA) filter. Plasma amino acid concentrations were deter-
mined using automatic amino acid analyser AAA-T339M
(Mikrotechna Praha, Czech Republic) according to the user’s
manual.
Fetal–maternal amino acid gradient was calculated as a ratio
between fetal and maternal concentration of certain amino acid
and was used for the assessment of placental concentration
function. Maternal glucose, cholesterol and other lipid and
lipoproteins fractions were determined by automated clinical
analyzer Sapphire 400 (Tokyo Boeki Ltd, Japan).
Statistical analysis
Means and standard errors are reported. After confirming
normality of dependent variables by the Kolmogorov–Smirnov
test, we analyzed the data. A t-test was used to compare means.
ANOVA, followed by Tukey’s test, was used to compare three
means. Correlation coefficients between ApoA, ApoB con-
centrations and amino acid concentrations were calculated by
Pearson’s method. The STATISTICA 10.0 (StatSoft) package
was used. Significance was accepted at P< 0.05.
Results
The characteristics of the subjects are shown in Table 1.
The mothers of all groups were matched for the age. There
were significant differences for body mass index (BMI)
Table 1. Clinical characteristics of the mothers and infants involved in
the study
Parameter
Normal
pregnancy
(n = 28)
Ob-AGA
group
(n = 46)
Ob-SGA
group
(n = 44)
Mothers
Age at delivery
(years)
29.8 ± 6.3 31.1 ± 5.4 32.2 ± 5.6
BMI (kg/m2) 22.1 ± 1.3 33.4 ± 1.6a 34.1 ± 1.8a
Birth weight (g) 3437 ± 344 3276 ± 234 2523 ± 105a,b
Neonates
Gestational age
(weeks)
38.4 ± 0.2 38.3 ± 0.3 38.1 ± 0.4
Birth weight (g) 3290 ± 60 3276 ± 234 2632 ± 102a,b
Placental weight (g) 400.5 ± 89.1 495.5 ± 96.2 420.0 ± 67.2
Fetal weight/
placental weight
ratio
8.22 ± 0.65 6.62 ± 2.37 6.26 ± 1.53
Sex
Male 16 21 24
Female 12 25 20
aP< 0.05 compared with normal pregnancy values
bP< 0.05 compared with Ob-AGA group.
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between mothers of the control and both obesity groups. The
mean birth weight of Ob-SGA group of mothers was
significantly lower than that of the control and Ob-AGA
groups of mothers.
The mean birth weight of infants of the Ob-AGA group was
not essentially different from that of infants in the control
group. The infants of Ob-SGA group mothers were on average
smaller at birth than the infants from mothers of the control
and Ob-AGA groups. There were no significant changes in
placental weight and fetal weight/placental weight ratios
between all groups of women.
Maternal cholesterol and lipoprotein concentrations
The main serum total cholesterol concentration was sig-
nificantly higher in mothers of Ob-SGA group than in both the
control and Ob-AGA group (Table 2). Triglyceride con-
centration was higher in Ob-SGA group than in the control
group. High-density lipoprotein (HDL) cholesterol was
significantly less in both Ob-AGA and Ob-SGA groups than in
the control group of mothers. However, low-density lipopro-
tein (LDL) cholesterol was increased only in Ob-SGA
group, apolipoprotein AI was also significantly increased in
Ob-SGA group in comparison with Ob-AGA and the control
groups. The most dramatic difference between groups was
shown in total cholesterol/HDL ratio, which was almost
two-fold higher in Ob-SGA group than in the control. This
ratio was also significantly increased in Ob-AGA group com-
paring to the control group. There were no significant differ-
ences between fasting glucose concentrations in all groups of
mothers.
Maternal amino acids in obese women
The mean concentration of most maternal amino acids was
lower in both groups of obese women. Results for all amino
acids required for protein synthesis and their summed total are
shown in Table 3. Nine essential and five non-essential amino
acids concentrations (except tyrosine) were significantly lower
in Ob-AGA and Ob-SGA groups than in the control group
mothers. However, the decrease in amino acid concentrations
was more prominent in Ob-SGA group. The concentration of
lysine in Ob-SGA group was two times lower than in the
control group. Lysine concentration in Ob-AGA main group
was only 1.3 times lower than in the control.
The mean total amino acid concentration for women of Ob-
SGA group (525.1 ± 64.0 µM/l) was significantly decreased
compared with women of Ob-AGA (845.6 ± 83.8 µM/l) and
the control (1547.2 ± 120.3 µM/l) groups. Also there was a
significant difference between total amino acid concentration
in Ob-AGA and the control groups.
Table 2. Mean fasting lipid, lipoprotein and glucose concentrations in pregnant women of control and two obese groups
Parameter Normal pregnancy (n = 28) Ob-AGA group (n = 46) Ob-SGA group (n = 44)
Total cholesterol (mM/l) 5.39 ± 0.41 5.04 ± 0.35a 6.94 ± 0.46a,b
Triglyceride (mM/l) 2.05 ± 0.32 2.65 ± 0.28 3.34 ± 0.46a
HDL cholesterol (mM/l) 1.81 ± 0.26 1.26 ± 0.19a 1.04 ± 0.14a
LDL cholesterol (mM/l) 3.03 ± 0.28 3.14 ± 0.19 3.82 ± 0.14a,b
ApoAI (g/l) 1.85 ± 0.29 2.24 ± 0.40 3.64 ± 0.68a,b
ApoAII (g/l) 0.59 ± 0.09 0.69 ± 0.18 0.79 ± 0.19
ApoB (g/l) 1.18 ± 0.20 2.01 ± 0.32 2.32 ± 0.13a
Total cholesterol/HDL 2.97 ± 0.18 4.01 ± 0.58a 6.57 ± 0.96a,b
Glucose (mM/l) 3.68 ± 0.45 3.79 ± 0.43 4.23 ± 0.58
aP< 0.05 compared with normal pregnancy values.
bP< 0.05 compared with Ob-AGA group.
Table 3. Maternal plasma amino acid concentrations (µM/l) in control,
Ob-AGA and Ob-SGA groups
Amino
acid
Normal pregnancy
(n = 28)
Ob-AGA group
(n = 46)
Ob-SGA group
(n = 44)
Essential
Trp 66.9 ± 2.9 18.6 ± 3.1a 18.0 ± 5.5a
Lys 146.4 ± 18.5 109.8 ± 10.2 72.7 ± 6.2a,b
His 92.2 ± 5.1 65.0 ± 4.2a 32.1 ± 3.6a,b
Thr 182.2 ± 12.1 118.3 ± 17.3a 108.8 ± 11.5a
Val 161.4 ± 7.5 54.1 ± 6.2a 58.1 ± 4.9a
Met 24.5 ± 6.5 6.4 ± 1.2a 6.5 ± 0.8a
Leu 118.4 ± 9.5 58.6 ± 6.0a 36.5 ± 5.3a,b
Ile 48.9 ± 6.4 28.6 ± 7.3a 13.8 ± 5.5a
Phe 83.4 ± 7.2 35.8 ± 8.1a 23.5 ± 7.4a
Non-essential
Arg 82.3 ± 4.7 65.1 ± 3.6a 27.2 ± 3.1a,b
Ser 83.9 ± 5.7 54.5 ± 4.5a 39.4 ± 3.6a,b
Ala 245.8 ± 29.4 179.4 ± 15.6a 73.7 ± 6.4a,b
Glu 56.8 ± 6.8 48.3 ± 5.4 27.9 ± 4.9a,b
Tyr 35.6 ± 4.1 32.7 ± 3.6 24.2 ± 2.8
Gly 118.5 ± 6.9 105.4 ± 6.5 88.9 ± 9.5a,b
Total 1547.2 ± 120.3 845.6 ± 83.8a 525.1 ± 64.0a,b
aP< 0.05 compared with normal pregnancy values.
bP< 0.05 compared with Ob-AGA group.
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Relationship between amino acid concentrations and ApoA,
ApoB in maternal plasma
As shown in Table 4 there are negative correlations between
ApoA and threonine in the Ob-SGA group, between ApoA and
valine, methionine, leucine, arginine in all three groups of women
and between ApoA and serine in the Ob-AGA and Ob-SGA
groups. Table 5 demonstrates inverse correlation between ApoB
and lysine and hystidine in Ob-AGA and Ob-SGA groups and
between ApoB and following amino acids: valine, arginine, ser-
ine, alanine and glycine in all three groups of women.
Cord blood amino acid concentrations
Obese pregnancy groups had lower umbilical venous plasma
amino acid concentrations (except glutamine, tyrosine and
glycine for Ob-AGA and glutamine for Ob-SGA groups) than
the control pregnancy group (Table 6).
Table 4. Correlation coefficients and P-values between ApoA and amino acid concentrations in maternal plasma
Normal pregnancy (n = 28) Ob-AGA group (n = 46) Ob-SGA group (n = 44)
Amino acid Coefficient P-value Coefficient P-value Coefficient P-value
Essential
Trp 0.159 0.458 0.241 0.145 –0.137 0.210
Lys –0.314 0.135 –0.362 0.084 –0.255 0.230
His –0.191 0.372 –0.154 0.631 –0.345 0.029
Thr –0.331 0.036* –0.296 0.041 –0.446 0.021*
Val –0.407 0.047* –0.395 0.045* –0.497 0.015*
Met –0.395 0.048* –0.496 0.018* –0.398 0.031*
Leu –0.397 0.041* –0.510 0.008* –0.570 0.006*
Ile –0.417 0.039* –0.386 0.048* –0.510 0.019*
Phe –0.028 0.850 –0.115 0.501 –0.361 0.085
Non-essential
Arg –0.446 0.029* –0.339 0.012* –0.467 0.028*
Ser –0.312 0.176 –0.481 0.021* –0.448 0.031*
Ala –0.510 0.009* –0.501 0.008* –0.495 0.021*
Glu –0.345 0.291 –0.316 0.187 –0.215 0.101
Tyr –0.287 0.174 –0.159 0.451 –0.203 0.341
Gly 0.251 0.219 –0.287 0.174 –0.335 0.109
*P< 0.05.
Table 5. Correlation coefficients and P-values between ApoB and amino acid concentrations in maternal plasma
Normal pregnancy (n = 28) Ob-AGA group (n = 46) Ob-SGA group (n = 44)
Amino acid Coefficient P-value Coefficient P-value Coefficient P-value
Essential
Trp 0.260 0.218 –0.162 0.312 –0.135 0.134
Lys –0.364 0.079 –0.415 0.021* –0.475 0.019*
His –0.181 0.367 –0.445 0.029* –0.396 0.041*
Thr –0.221 0.101 –0.289 0.175 –0.334 0.106
Val –0.508 0.010* –0.484 0.032* –0.401 0.045*
Met –0.203 0.342 –0.160 0.605 –0.204 0.319
Leu –0.202 0.296 –0.109 0.675 –0.221 0.321
Ile –0.054 0.810 –0.261 0.270 –0.250 0.213
Phe –0.318 0.091 –0.396 0.012 –0.287 0.201
Non-essential
Arg –0.452 0.038* –0.519 0.018* –0.578 0.019*
Ser –0.496 0.034* –0.528 0.027* –0.594 0.014*
Ala –0.498 0.030* –0.596 0.018* –0.481 0.043*
Glu –0.315 0.287 –0.216 0.087 –0.267 0.121
Tyr –0.137 0.186 –0.396 0.076 –0.328 0.065
Gly 0.598 0.021* –0.479 0.031* –0.489 0.016*
*P< 0.05.
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In normal pregnancy umbilical venous plasma concentrations
formost essential and non-essential amino acids (except leucine and
glutamine) were significantly higher than maternal concentrations
(high fetal–maternal amino acids gradient) (Table 7). The fetal–
maternal amino acid gradients were lowest in Ob-SGA group.
However, for several amino acids (Met, Leu, Ile, Phe) these gra-
dients were higher than in Ob-AGA and the control groups.
Discussion
This study shows a significant increase in serum lipids which is
more prominent in the Ob-SGA group. Women of this group
had serum concentration of total cholesterol that would be
considered as an increased risk of cardiovascular disease in
nonpregnant women. We have also shown that the con-
centrations of LDL cholesterol and their corresponding apoli-
poproteins B and AI are increased in women of Ob-SGA
group. The increase in total, LDL cholesterol and triglyceride
has been demonstrated during normal pregnancy.16,17 The
mechanism whereby pregnancy induces hyperlipidemia has not
been fully elucidated. The positive correlation between changes
in the lipid and lipoprotein concentration and pregnancy hor-
mones (estradiol, progesterone and human placental lactogen)
has been demonstrated.18
Although the significance of these changes in plasma lipids
and lipoproteins is uncertain, they are likely to relate to the
maintenance of energetic fuel to the fetus.19
Estrogens could be responsible for most of the changes in
lipoprotein metabolism during pregnancy, but its effects are
complemented and opposed by the other pregnancy hormones
(progesterone) and by increasing insulin resistance in late
pregnancy. Our study demonstrates that lipid and lipoprotein
concentration in obese pregnant women who themselves were
born SGA could be significantly increased in comparison with
the control women and women with diet-induced obesity.
We suggest that potentially the Ob-SGA group could be
atherogenic. The changes in lipid profile observed in women of
Ob-SGA group may be of potential importance for women’s
long-term health because elevated serum triglycerides are
independent risk factors for coronary heart disease in women.20
The complex nature of apolipoproteins synthesis and meta-
bolism has been demonstrated in many studies based upon the
use of labeled amino acids.21,22 In this study we assessed the
relationship between ApoA, ApoB and several amino acids
concentrations in maternal plasma. Negative correlations
(correlation coefficients from −0.3 to −0.5) were seen between
these apolipoproteins and several amino acids concentrations.
Negative correlation between ApoA and threonine concentra-
tion was demonstrated only in Ob-SGA group and between
ApoA and serine concentration in both groups of obese
mothers. Inverse correlations between ApoB and lysine,
hystidine concentrations were also seen only in obese women.
Earlier the inverse association was demonstrated between
intakes of alanine, isoleucine, methionine, serine, tryptophan,
tyrosine and ApoA/ApoB ratio among female adolescents.23
One can speculate that the increase of the amino acids con-
tribution to the synthesis of apolipoproteins could diminish the
role of such amino acids as an energetic fuel to the fetus.
Table 6. Newborn infants plasma amino acid concentrations (µM/l) in
control, Ob-AGA and Ob-SGA groups
Amino
acid
Normal pregnancy
(n = 28)
Ob-AGA group
(n = 46)
Ob-SGA group
(n = 44)
Essential
Trp 88.4 ± 9.3 21.7 ± 3.7a 14.6 ± 3.4a
Lys 372.7 ± 25.8 145.1 ± 17.4a 107.1 ± 12.5a,b
His 169.5 ± 9.6 74.7 ± 6.5a 38.4 ± 3.7a,b
Thr 268.4 ± 32.4 169.7 ± 24.7a 114.1 ± 19.5a,b
Val 218.7 ± 34.1 60.8 ± 4.7a 59.7 ± 4.5a
Met 30.6 ± 2.4 7.9 ± 2.1a 12.2 ± 2.9a,b
Leu 123.5 ± 18.9 66.9 ± 8.1a 48.1 ± 6.2a
Ile 67.4 ± 6.1 32.6 ± 5.2a 20.7 ± 4.6a,b
Phe 88.4 ± 8.7 39.7 ± 6.4a 39.8 ± 3.6a
Non-essential
Arg 97.7 ± 11.7 34.2 ± 3.8a 26.3 ± 2.4a
Ser 142.6 ± 31.5 59.8 ± 7.9a 54.2 ± 6.2a
Ala 320.1 ± 38.6 163.2 ± 12.5a 102.4 ± 8.4a,b
Glu 28.9 ± 3.7 23.4 ± 1.5 23.1 ± 5.0
Tyr 62.6 ± 8.7 58.2 ± 6.1 32.2 ± 5.5a,b
Gly 241.7 ± 48.4 164.3 ± 27.5 123.2 ± 18.6a
Total 2321.3 ± 289.9 1122.2 ± 138.1a 816.1 ± 107.0a
aP< 0.05 compared with normal pregnancy values.
bP< 0.05 compared with Ob-AGA group.
Table 7. Fetal–maternal amino acid gradients for control and
obesity groups
Amino
acid
Normal pregnancy
(n = 28)
Ob-AGA group
(n = 46)
Ob-SGA group
(n = 44)
Essential
Trp 1.31 ± 0.17 1.16 ± 0.10 0.81 ± 0.07a
Lys 2.54 ± 0.24 1.31 ± 0.18a 1.57 ± 0.11a
His 1.83 ± 0.18 1.49 ± 0.09a 1.19 ± 0.12a
Thr 1.47 ± 0.17 1.43 ± 0.19 1.05 ± 0.06
Val 1.35 ± 0.21 1.11 ± 0.14 0.91 ± 0.06a
Met 1.22 ± 0.14 1.13 ± 0.15 1.32 ± 0.09
Leu 1.04 ± 0.08 1.15 ± 0.07 1.31 ± 0.10
Ile 1.36 ± 0.14 1.15 ± 0.18 1.49 ± 0.16
Phe 1.06 ± 0.05 1.12 ± 0.16 1.70 ± 0.21
Non-essential
Arg 1.95 ± 0.20 0.52 ± 0.06a 0.97 ± 0.04a,b
Ser 1.69 ± 0.18 1.10 ± 0.14a 1.38 ± 0.11
Ala 1.30 ± 0.09 0.91 ± 0.07a 1.39 ± 1.39
Glu 0.50 ± 0.04 0.48 ± 0.03 0.82 ± 0.09a
Tyr 1.77 ± 0.12 1.75 ± 0.13 1.32 ± 0.14
Gly 2.04 ± 0.16 1.76 ± 0.14a 1.30 ± 0.09a,b
aP< 0.05 compared with normal pregnancy values.
bP< 0.05 compared with Ob-AGA group.
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It was shown earlier, that women who were SGA at birth are
at increased risk of developing hypertension during preg-
nancy.24 Also it was shown that maternal hypercholesterolemia
dramatically raised the cumulative area of intimal lipid accu-
mulation and the area of the largest lesion per fetal aortic sec-
tion, increasing offspring risk of future cardiovascular disease.25
Our results support the Barker theory that malnutrition and
impaired fetal growth are associated with an increased risk of
developing a variety of risk factors for cardiovascular disease,
including dyslipidemia during adulthood.26
Amino acids
Amino acids along with glucose and lactate represent major
nutrients used by fetus both for protein synthesis and oxida-
tion.8 It is demonstrated that amino acid concentrations are
higher in the fetal than in maternal body. Number of studies
has provided evidence for significant participation of placenta
in amino acid metabolism.27
Amino acids uptake across the syncytiotrophoblastmembranes is
mediated through active transporters and exchangers. Active accu-
mulative transporters increase intracellular amino acid concentra-
tions by transferring these substances against their concentration
gradient, usually by co-transporting extracellular sodium.28
Exchangers are able to modify amino acid content by exchanging
amino acids between intracellular and extracellular compartments.
The placenta not only concentrates amino acids in the fetal
compartment but is also involved in synthesis of some non-
essential amino acids. As recently demonstrated, some external
factors may regulate the activity of amino acid transporters
(such as oxygenation, insulin, leptin).29
Fetal intrauterine growth is the result of interaction between
maternal–placental nutrient supply and genetically determined
growth potential.8 Some factors may influence fetal nutritional
supply: maternal nutrition, uteroplacental circulation, and
placental transfer capacity.30 We demonstrated that newborn
infants of Ob-SGA group women were born SGA. Moreover,
in this group umbilical concentrations for most amino acids
were significantly lower than in the control and even in
Ob-AGA group. Earlier it was shown that concentration of
most amino acids is significantly decreased both in the umbi-
lical artery and vein of intrauterine growth restriction (IUGR)
pregnancies when it compared to normally grown babies.31,32
However, in IUGR maternal concentrations of the most
essential amino acids were significantly higher than in preg-
nancies with appropriate for gestational age fetuses.31
In IUGR pregnancies, increasing the maternal concentration
of amino acids leads to an increased umbilical uptake of some of
the amino acids to the fetus. However, the changes in the uptake
of the essential amino acids such as lysine, histidine, threonine,
valine, and phenylalanine suggest the presence of competition for
the same transporter that might diminish the transport.33 Studies
in human pregnancies demonstrate that during constant infusion
of L-[1-13C]-leucine, the fetal–maternal leucine gradient
decreases in IUGR in parallel with clinical severity.33 It was
suggested than not only the transplacental transport of leucine is
impaired but also a possible increased protein catabolism in
IUGR pregnancies.35 The injection as a bolus of two essential
amino acids, leucine and phenylalanine demonstrated in IUGR
pregnancies decreased fetal–maternal gradient in comparison
with AGA pregnancies, whereas no differences were presented for
the nonessential amino acids glycine and proline.34
We have demonstrated that Ob-SGA group had the lowest
fetal–maternal amino acid gradients for most amino acids that
could reflect the impaired concentration/synthetic function of
the placenta. However, these gradients for Met, Leu, Ile, Phe
were higher in Ob-SGA group than in other groups of women.
It could be the result of changing the balance between placental
amino acid transporting systems in such type of obesity. Many
types of these systems have been identified in the placenta.8
Each transporter is highly stereospecific, but different trans-
porting systems have overlapping substrate specificity, with
possible compensation of one system by another.8
It is interesting that we demonstrated increase in fetal–
maternal gradient for leucine and phenylalanine in OB-SGA
group in contrary to the results shown by Paolini et al.34 One
can speculate that changes in placental transporting function in
obese mothers born themselves SGA significantly differ from
corresponding placental changes in IUGR.
The fetal growth and metabolism are adaptive processes and
programmed by the intrauterine nutrition and environment.35
Furthermore, as suggested earlier, the placenta could play a role
of a nutrient sensor.36 If the placenta senses the fetal environ-
ment with low nutrient levels, it increases its transport activity
to support normal fetal growth. On the other hand, if there is
an insufficient nutrient supply at the maternal site, the placenta
may diminish its transport activity, adapting fetal growth to a
lower level, in order to reduce the postnatal demand.31
In our study, decreased fetal–maternal amino acid gradients
for most amino acids observed in Ob-SGA group suggest that
placental amino acid exchange and/or fetal–placental metabo-
lism are altered in obese women who were born SGA. We can
also suggest that hypercholesterolemia in Ob-SGA women
could affect the fetal amino acid metabolism due to the reci-
procal relationship between fetal energy supply and placental
amino acid transport. One can speculate that significant
changes in lipids and apolipoproteins metabolism during the
intrauterine development of Ob-SGA women affected future
placental function in a specific manner that resulted in the
development of low birth weight infants.
Limitation
The limitation of this research project is that authors have no
complete information on the cause of maternal SGA women of
Ob-SGA group.
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